Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women

L. Stewart Massad, Charlesnika T. Evans, Howard Minkoff, D. Heather Watts, Ruth M. Greenblatt, Alexandra M. Levine, Kathryn Anastos, Mary Young, David B. Seifer, Elizabeth Golub, Mardge Cohen

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: To describe menstrual abnormalities among women with HIV. Methods: Women in a multicenter prospective cohort study of HIV natural history reported menstrual abnormalities every 6-months between October 1994 and September 2002. Logistic regression and Cox proportional-hazards models were applied. Results: The prevalence and incidence of menstrual abnormalities were <20%. HIV serostatus was not associated with prevalent menstrual abnormalities, but in HIV-seropositive women, higher CD4 counts were associated with fewer problems: compared with women with CD4 counts <200/mm3, in women with counts 200-500/mm3, odds ratio (OR) for amenorrhea was 0.55, p = 0.02, and for oligomenorrhea was 0.54, p = 0.0003; for women with counts >500/mm3, OR for amenorrhea was 0.67, p = 0.14, and for oligomenorrhea was 0.55, p = 0.001. HIV serostatus was not associated with incident abnormalities. Highly active anti-retroviral therapy (HAART) use was not associated with prevalent abnormalities, but both HAART use and higher CD4 counts were linked to lower rates of incident menstrual problems. Conclusions: Compared with seronegative women, HIV-seropositive women are at increased risk for some menstrual changes, although the absolute frequency of most abnormalities is low. Higher CD4 counts and HAART protect against incident abnormalities.

Original languageEnglish (US)
Pages (from-to)591-598
Number of pages8
JournalJournal of Women's Health
Volume15
Issue number5
DOIs
StatePublished - Jun 2006

Fingerprint

HIV Infections
HIV
CD4 Lymphocyte Count
Oligomenorrhea
Amenorrhea
Therapeutics
Natural History
Proportional Hazards Models
Cohort Studies
Logistic Models
Prospective Studies
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Massad, L. S., Evans, C. T., Minkoff, H., Watts, D. H., Greenblatt, R. M., Levine, A. M., ... Cohen, M. (2006). Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. Journal of Women's Health, 15(5), 591-598. https://doi.org/10.1089/jwh.2006.15.591

Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. / Massad, L. Stewart; Evans, Charlesnika T.; Minkoff, Howard; Watts, D. Heather; Greenblatt, Ruth M.; Levine, Alexandra M.; Anastos, Kathryn; Young, Mary; Seifer, David B.; Golub, Elizabeth; Cohen, Mardge.

In: Journal of Women's Health, Vol. 15, No. 5, 06.2006, p. 591-598.

Research output: Contribution to journalArticle

Massad, LS, Evans, CT, Minkoff, H, Watts, DH, Greenblatt, RM, Levine, AM, Anastos, K, Young, M, Seifer, DB, Golub, E & Cohen, M 2006, 'Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women', Journal of Women's Health, vol. 15, no. 5, pp. 591-598. https://doi.org/10.1089/jwh.2006.15.591
Massad, L. Stewart ; Evans, Charlesnika T. ; Minkoff, Howard ; Watts, D. Heather ; Greenblatt, Ruth M. ; Levine, Alexandra M. ; Anastos, Kathryn ; Young, Mary ; Seifer, David B. ; Golub, Elizabeth ; Cohen, Mardge. / Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. In: Journal of Women's Health. 2006 ; Vol. 15, No. 5. pp. 591-598.
@article{d7cc498e3411480d9760a8cf83ac44f0,
title = "Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women",
abstract = "Objective: To describe menstrual abnormalities among women with HIV. Methods: Women in a multicenter prospective cohort study of HIV natural history reported menstrual abnormalities every 6-months between October 1994 and September 2002. Logistic regression and Cox proportional-hazards models were applied. Results: The prevalence and incidence of menstrual abnormalities were <20{\%}. HIV serostatus was not associated with prevalent menstrual abnormalities, but in HIV-seropositive women, higher CD4 counts were associated with fewer problems: compared with women with CD4 counts <200/mm3, in women with counts 200-500/mm3, odds ratio (OR) for amenorrhea was 0.55, p = 0.02, and for oligomenorrhea was 0.54, p = 0.0003; for women with counts >500/mm3, OR for amenorrhea was 0.67, p = 0.14, and for oligomenorrhea was 0.55, p = 0.001. HIV serostatus was not associated with incident abnormalities. Highly active anti-retroviral therapy (HAART) use was not associated with prevalent abnormalities, but both HAART use and higher CD4 counts were linked to lower rates of incident menstrual problems. Conclusions: Compared with seronegative women, HIV-seropositive women are at increased risk for some menstrual changes, although the absolute frequency of most abnormalities is low. Higher CD4 counts and HAART protect against incident abnormalities.",
author = "Massad, {L. Stewart} and Evans, {Charlesnika T.} and Howard Minkoff and Watts, {D. Heather} and Greenblatt, {Ruth M.} and Levine, {Alexandra M.} and Kathryn Anastos and Mary Young and Seifer, {David B.} and Elizabeth Golub and Mardge Cohen",
year = "2006",
month = "6",
doi = "10.1089/jwh.2006.15.591",
language = "English (US)",
volume = "15",
pages = "591--598",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women

AU - Massad, L. Stewart

AU - Evans, Charlesnika T.

AU - Minkoff, Howard

AU - Watts, D. Heather

AU - Greenblatt, Ruth M.

AU - Levine, Alexandra M.

AU - Anastos, Kathryn

AU - Young, Mary

AU - Seifer, David B.

AU - Golub, Elizabeth

AU - Cohen, Mardge

PY - 2006/6

Y1 - 2006/6

N2 - Objective: To describe menstrual abnormalities among women with HIV. Methods: Women in a multicenter prospective cohort study of HIV natural history reported menstrual abnormalities every 6-months between October 1994 and September 2002. Logistic regression and Cox proportional-hazards models were applied. Results: The prevalence and incidence of menstrual abnormalities were <20%. HIV serostatus was not associated with prevalent menstrual abnormalities, but in HIV-seropositive women, higher CD4 counts were associated with fewer problems: compared with women with CD4 counts <200/mm3, in women with counts 200-500/mm3, odds ratio (OR) for amenorrhea was 0.55, p = 0.02, and for oligomenorrhea was 0.54, p = 0.0003; for women with counts >500/mm3, OR for amenorrhea was 0.67, p = 0.14, and for oligomenorrhea was 0.55, p = 0.001. HIV serostatus was not associated with incident abnormalities. Highly active anti-retroviral therapy (HAART) use was not associated with prevalent abnormalities, but both HAART use and higher CD4 counts were linked to lower rates of incident menstrual problems. Conclusions: Compared with seronegative women, HIV-seropositive women are at increased risk for some menstrual changes, although the absolute frequency of most abnormalities is low. Higher CD4 counts and HAART protect against incident abnormalities.

AB - Objective: To describe menstrual abnormalities among women with HIV. Methods: Women in a multicenter prospective cohort study of HIV natural history reported menstrual abnormalities every 6-months between October 1994 and September 2002. Logistic regression and Cox proportional-hazards models were applied. Results: The prevalence and incidence of menstrual abnormalities were <20%. HIV serostatus was not associated with prevalent menstrual abnormalities, but in HIV-seropositive women, higher CD4 counts were associated with fewer problems: compared with women with CD4 counts <200/mm3, in women with counts 200-500/mm3, odds ratio (OR) for amenorrhea was 0.55, p = 0.02, and for oligomenorrhea was 0.54, p = 0.0003; for women with counts >500/mm3, OR for amenorrhea was 0.67, p = 0.14, and for oligomenorrhea was 0.55, p = 0.001. HIV serostatus was not associated with incident abnormalities. Highly active anti-retroviral therapy (HAART) use was not associated with prevalent abnormalities, but both HAART use and higher CD4 counts were linked to lower rates of incident menstrual problems. Conclusions: Compared with seronegative women, HIV-seropositive women are at increased risk for some menstrual changes, although the absolute frequency of most abnormalities is low. Higher CD4 counts and HAART protect against incident abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=33746122966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746122966&partnerID=8YFLogxK

U2 - 10.1089/jwh.2006.15.591

DO - 10.1089/jwh.2006.15.591

M3 - Article

C2 - 16796486

AN - SCOPUS:33746122966

VL - 15

SP - 591

EP - 598

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 5

ER -